Showing results (191-200 of 301) with videos related to

Sort By:
Pageof 31
British Journal of Clinical Pharmacology|March 27, 2016
Adverse drug event reporting systems: a systematic reviewChantelle Bailey, David Peddie, Maeve E Wickham, et al.
JMIR Research Protocols|August 20, 2016
Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods DesignDavid Peddie, Serena S Small, Katherin Badke, et al.
Cureus|March 31, 2025
Characterizing the Association Between Asthma and Clinical Outcomes in Emergency Department Patients With Symptomatic COVID-19Bachar Al Mazloum, Harriet Richardson, Yingwei Peng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2022
Cutting Edge: Neutrophils License the Maturation of Monocytes into Effective Antifungal EffectorsVanessa Espinosa, Orchi Dutta, Lena J Heung, et al.
Journal of Neurochemistry|July 1, 1992
Cell swelling, blebbing, and death are dependent on ATP depletion and independent of calcium during chemical hypoxia in a glial cell line (ROC-1)M S Jurkowitz-Alexander, R A Altschuld, C M Hohl, et al.
CJEM|July 24, 2010
Patient-reported adverse drug-related events from emergency department discharge prescriptionsCorinne M Hohl, Riyad B Abu-Laban, Peter J Zed, et al.
Plos Pathogens|September 26, 2014
Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infectionKelly M Shepardson, Anupam Jhingran, Alayna Caffrey, et al.
BMC Emergency Medicine|July 14, 2022
Characterizing people with frequent emergency department visits and substance use: a retrospective cohort study of linked administrative data in Ontario, Alberta, and B.C., CanadaJessica Moe, Yueqiao Elle Wang, Michael J Schull, et al.
Annals of Emergency Medicine|March 1, 2011
Outcomes of emergency department patients presenting with adverse drug eventsCorinne M Hohl, Bohdan Nosyk, Lisa Kuramoto, et al.
JAMA Network Open|October 12, 2022
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the HospitalCorinne M Hohl, Jeffrey P Hau, Samuel Vaillancourt, et al.
Pageof 31